Cited by 2,020Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorMental Health and Psychiatry

The DOI matches its Crossref record; 398 of the 399 references it cites were found in a registry or an index.

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P J, Weinberger, D R·2005·Molecular Psychiatry

DOI 10.1038/sj.mp.4001558

Open this paper in CoChat — free account

Abstract

This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence. The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in the hippocampus, dorsolateral prefrontal cortex, and dorsal thalamus. These findings have fostered the view of schizophrenia as a disorder of connectivity and of the synapse. Although attractive, such concepts are vague, and differentiating primary events from epiphenomena has been difficult. A way forward is provided by the recent identification of several putative susceptibility genes (including neuregulin, dysbindin, COMT, DISC1, RGS4, GRM3, and G72). We discuss the evidence for these and other genes, along with what is known of their expression profiles and biological roles in brain and how these may be altered in schizophrenia. The evidence for several of the genes is now strong. However, for none, with the likely exception of COMT, has a causative allele or the mechanism by which it predisposes to schizophrenia been identified. Nevertheless, we speculate that the genes may all converge functionally upon schizophrenia risk via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry. NMDA receptor-mediated glutamate transmission may be especially implicated, though there are also direct and indirect links to dopamine and GABA signalling. Hence, there is a correspondence between the putative roles of the genes at the molecular and synaptic levels and the existing understanding of the disorder at the neural systems level. Characterization of a core molecular pathway and a 'genetic cytoarchitecture' would be a profound advance in understanding schizophrenia, and may have equally significant therapeutic implications.

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4001558

Cites

398 of 398 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Self-citation
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citation
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788

Show all 399 references

Research works printed but not linked: 4

Grossman MH, Littrel JB, Weinstein R, Szumlanski C, Weinshilboum R . Identification of the possible basis for inherited differences in human catechol-O-methyltransferase. Trans Neurosci Soc 1992; 18: 70.
Straub RE, Egan MF, Hashimoto R, Matsumoto M, Weickert CS, Goldberg T et al. The schizophrenia susceptibility gene dysbindin (DTNBP1, 6p22.3): analysis of haplotypes, intermediate phenotypes, and alternative transcripts. Biol Psychiatry 2003; 53: 167S.
Callicott JH, Pezeawas L, Egan MF, Hariri AR, Mattay VS, Goldberg TE et al. Genetic variationVariation in DISC-1 affects hippocampal structure and function associated with increased risk for schizophrenia and with normal hippocampal structure and function. (in review).
Toro CT, Kasher PR, Deakin JFW . Altered D-serine metabolism in schizophrenia? A post-mortem study using Stanley Consortium brains [Abstract]. Schizophr Res 2004; 67(Suppl): 125.

Sorted by citations

Items 901–1,000 of 1,003

Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia
Amar, S., Shaltiel, G., Mann, L., Shamir, A., Dean, B., Scarr, E., Bersudsky, Y., Belmaker, R. H., & Agam, G. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707007948 · Cited by 38
Monkey Prefrontal Neurons Reflect Logical Operations for Cognitive Control in a Variant of the AX Continuous Performance Task (AX-CPT)
Blackman, R. K., Crowe, D. A., DeNicola, A. L., Sakellaridi, S., MacDonald, A. W., & Chafee, M. V. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3578-15.2016 · Cited by 35
Social Isolation Rearing Affects Prefrontal Cortical Response To Ventral Tegmental Area Stimulation
Peters, Y. M., & O’Donnell, P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.011 · Cited by 38
Role of disrupted in schizophrenia 1 (DISC1) in stress-induced prefrontal cognitive dysfunction
Gamo, N. J., Duque, A., Paspalas, C. D., Kata, A., Fine, R., Boven, L., Bryan, C., Lo, T., Anighoro, K., Bermudez, L., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.104 · Cited by 37
The Effect of Probiotic Supplementation on the Gut–Brain Axis in Psychiatric Patients
Sabit, H., Kassab, A., Alaa, D., Mohamed, S., Abdel-Ghany, S. E., mansy, M. I. A., Said, O. A. M., Khalifa, M. A., Hafiz, H., & Abushady, A. M. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45050260 · Cited by 41
Neuronal distribution in the neocortex of schizophrenic patients
Casanova, M. F., Kreczmański, P., Trippe, J., Switala, A. E., Heinsen, H., Steinbusch, H. W. M., & Schmitz, C. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2006.12.009 · Cited by 37
Association study of Neuregulin-1 gene polymorphisms in a north Indian schizophrenia sample
Kukshal, P., Triptish Bhatia, A., Bhagwat, A. M., Gur, R. E., Gur, R. C., Deshpande, S. N., Nimgaonkar, V. L., & Thelma, B. K. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2012.12.017 · Cited by 36
Type III Neuregulin 1 Is Required for Multiple Forms of Excitatory Synaptic Plasticity of Mouse Cortico-Amygdala Circuits
Jiang, L., Emmetsberger, J., Talmage, D. A., & Role, L. W. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2888-12.2013 · Cited by 37
Comprehensive analysis of polymorphisms throughout GAD1 gene: a family-based association study in schizophrenia
Du, J., Duan, S., Wang, H., Chen, W., Zhao, X., Zhang, A., Wang, L., Xuan, J., Yu, L., Wu, S., et al. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0844-z · Cited by 37
Glutamate Dehydrogenase–Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction
Lander, S. S., Khan, U., Lewandowski, N. M., Chakraborty, D., Provenzano, F. A., Mingote, S., Chornyy, S., Frigerio, F., Maechler, P., Kaphzan, H., et al. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby011 · Cited by 38
The Homer1 family of proteins at the crossroad of dopamine-glutamate signaling: An emerging molecular “Lego” in the pathophysiology of psychiatric disorders. A systematic review and translational insight
de Bartolomeis, A., Barone, A., Buonaguro, E. F., Tomasetti, C., Vellucci, L., & Iasevoli, F. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104596 · Cited by 40
Behavioral Animal Models of Antipsychotic Drug Actions
Peleg‐Raibstein, D., Feldon, J., & Meyer, U. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_14 · Cited by 39
A putative high risk diplotype of the G72 gene is in healthy individuals associated with better performance in working memory functions and altered brain activity in the medial temporal lobe
Jansen, A., Krach, S., Krug, A., Markov, V., Eggermann, T., Zerres, K., Stöcker, T., Shah, N. J., Nöthen, M. M., Treutlein, J., et al. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2008.12.054 · Cited by 37
D-Aspartate: An Atypical Amino Acid with Neuromodulatory Activity in Mammals
Errico, F., Napolitano, F., Nisticò, R., Centonze, D., & Usiello, A. (2009) · Reviews in the Neurosciences · doi:10.1515/revneuro.2009.20.5-6.429 · Cited by 37
An exploratory model for G×E interaction on hippocampal volume in schizophrenia; obstetric complications and hypoxia-related genes
Haukvik, U. K., Saetre, P., McNeil, T. F., Bjerkan, P. S., Andreassen, O. A., Werge, T. M., Jönsson, E. G., & Agartz, I. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.001 · Cited by 37
Neurodevelopmental involvement in schizophrenia: the olfactory epithelium as an alternative model for research
Cascella, N. G., Takaki, M., Lin, S. Y., & Sawa, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04628.x · Cited by 37
MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms
Ho, B. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.08.001 · Cited by 37
Association study between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia: A meta-analysis
Li, D., & He, L. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.05.017 · Cited by 37
Genetic Variations of the NR3A Subunit of the NMDA Receptor Modulate Prefrontal Cerebral Activity in Humans
Gallinat, J., Götz, T., Kalus, P., Bajbouj, M., Sander, T., & Winterer, G. (2007) · Journal of Cognitive Neuroscience · doi:10.1162/jocn.2007.19.1.59 · Cited by 37
Analysis of polymorphisms in AT‐rich domains of neuregulin 1 gene in schizophrenia
Lachman, H. M., Pedrosa, E., Nolan, K. A., Glass, M., Ye, K. Q., & Saito, T. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30242 · Cited by 39
Antipsychotic drugs selectively decorrelate long-range interactions in deep cortical layers
Heindorf, M., & Keller, G. B. (2023) · eLife · doi:10.1101/2022.01.31.478462 · Cited by 61
Metabotropic Glutamate Receptors for New Treatments in Schizophrenia
Herman, E. J., Bubser, M., Conn, P. J., & Jones, C. K. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25758-2_11 · Cited by 37
A neuregulin 1 transmembrane domain mutation causes imbalanced glutamatergic and dopaminergic receptor expression in mice
Newell, K. A., Karl, T., & Huang, X. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.06.037 · Cited by 36
Neuroimaging and the question of neurodegeneration in schizophrenia
Meyer‐Lindenberg, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.07.007 · Cited by 36
Glutamate and Psychosis Risk
Egerton, A., Fusar-Poli, P., & M. Stone, J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799316244 · Cited by 36
Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes
Cassoli, J. S., Iwata, K., Steiner, J. H., Guest, P. C., Turck, C. W., Nascimento, J. M., & Martins‐de‐Souza, D. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00052 · Cited by 36
Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission
Fukuyama, K., Hasegawa, T., & Okada, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113645 · Cited by 37
Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling
Tseng, W. C., Reinhart, V., Lanz, T. A., Weber, M. L., Pang, J., Le, K. X., Bell, R. D., O’Donnell, P., & Buhl, D. L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01262-5 · Cited by 38
Haloperidol promotes proliferation but inhibits differentiation in rat oligodendrocyte progenitor cell culturesThis paper is one of a selection of papers published in this special issue entitled “Second International Symposium on Recent Advances in Basic, Clinical, and Social Medicine” and has undergone the Journal's usual peer review process.
Niu, J., Mei, F., Li, N., Wang, H., Li, X., Kong, J., & Xiao, L. (2010) · Biochemistry and Cell Biology · doi:10.1139/o09-178 · Cited by 36
New findings from genetic association studies of schizophrenia
Williams, H. J., Owen, M. J., & O’Donovan, M. C. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.7 · Cited by 35
Shared and distinct gray matter abnormalities in schizophrenia, schizophrenia relatives and bipolar disorder in association with cognitive impairment
Knöchel, C., Stäblein, M., Prvulovic, D., Ghinea, D., Wenzler, S., Pantel, J., Alves, G. S., Linden, D. E. J., Harrison, O., Carvalho, A. F., et al. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.035 · Cited by 35
Gene-Targeting Technologies for the Study of Neurological Disorders
Beglopoulos, V., & Shen, J. (2004) · NeuroMolecular Medicine · doi:10.1385/nmm:6:1:013 · Cited by 36
Convergent approaches for defining functional imaging endophenotypes in schizophrenia
Pearlson, G. D. (2009) · Frontiers in Human Neuroscience · doi:10.3389/neuro.09.037.2009 · Cited by 35
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential
Stadelmann, A. M., Juckel, G., Arning, L., Gallinat, J., Epplen, J. T., & Roser, P. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.04.003 · Cited by 35
The epigenome and postnatal environmental influences in psychotic disorders
Pishva, E., Kenis, G., van den Hove, D., Lesch, K., Boks, M. P., van Os, J., & Rutten, B. P. F. (2014) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-014-0831-2 · Cited by 36
Modulation of behavioral networks by selective interneuronal inactivation
Schmidt, M. J., Horváth, S., Ebert, P. J., Norris, J. L., Seeley, E. H., Brown, J. A., Gellért, L., Everheart, M., Garbett, K. A., Grice, T. W., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.167 · Cited by 34
Patterns of deficits in brain function in bipolar disorder and schizophrenia: A cluster analytic study
Hall, M., Smoller, J. W., Cook, N. R., Schulze, K., Lee, P. H., Taylor, G., Bramon, E., Coleman, M. J., Murray, R. M., Salisbury, D. F., et al. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.07.052 · Cited by 36
Understanding the impact of 5-HTTLPR, antidepressants, and acute tryptophan depletion on brain activation during facial emotion processing: A review of the imaging literature
Raab, K., Kirsch, P., & Mier, D. U. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.08.031 · Cited by 35
Longitudinal and cross-sectional investigations of long-term potentiation-like cortical plasticity in bipolar disorder type II and healthy individuals
Zak, N., Moberget, T., Bøen, E., Boye, B., Waage, T. R., Dietrichs, E., Harkestad, N., Malt, U. F., Westlye, L. T., Andreassen, O. A., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0151-5 · Cited by 37
A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia
Cadena, E. J., White, D. M., Kraguljac, N. V., Reid, M. A., Maximo, J. O., Nelson, E. A., Gawronski, B. A., & Lahti, A. C. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00632 · Cited by 35
Elevated serum anti-NMDA receptor antibody levels in first-episode patients with schizophrenia
Tong, J., Huang, J., Luο, X., Chen, S., Cui, Y., An, H., Xiu, M., Tan, S., Wang, Z., Yuan, Y., et al. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.017 · Cited by 35
Overview of Animal Models of Schizophrenia
Powell, S. B., & Geyer, M. A. (2007) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0924s39 · Cited by 35
Currently recognized genes for schizophrenia: High‐resolution chromosome ideogram representation
Butler, M. G., McGuire, A., Masoud, H., & Manzardo, A. M. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32391 · Cited by 35
Strain differences in the disruption of prepulse inhibition of startle after systemic and intra-accumbens amphetamine administration
Swerdlow, N. R., Shoemaker, J. M., Bongiovanni, M. J., Neary, A. C., Tochen, L. S., & Marie, R. L. S. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.03.014 · Cited by 35
An association study of RGS4 polymorphisms with clinical phenotypes of schizophrenia in a Chinese population
So, H., Chen, R. Y. L., Chen, E. Y. H., Cheung, E. F. C., Li, T., & Sham, P. C. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30577 · Cited by 35
Innovative clinical assessment technologies: Challenges and opportunities in neuroimaging.
Miller, G. A., Elbert, T. R., Sutton, B. P., & Heller, W. (2007) · Psychological Assessment · doi:10.1037/1040-3590.19.1.58 · Cited by 36
Grey-matter texture abnormalities and reduced hippocampal volume are distinguishing features of schizophrenia
Radulescu, E., Ganeshan, B., Shergill, S. S., Medford, N., Chatwin, C. R., Young, R. C., & Critchley, H. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.05.014 · Cited by 35
Integrating retinoic acid signaling with brain function.
Luo, T., Wagner, E., & Dräger, U. C. (2009) · Developmental Psychology · doi:10.1037/0012-1649.45.1.139 · Cited by 35
Comprehensive analysis of tagging sequence variants in DTNBP1 shows no association with schizophrenia or with its composite neurocognitive endophenotypes
Peters, K. E., Wiltshire, S., Henders, A., Dragovic, M., Badcock, J., Chandler, D., Howell, S., Ellis, C., Bouwer, S., Montgomery, G., et al. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30741 · Cited by 39
Dysfunctional Brain Networks and Genetic Risk for Schizophrenia: Specific Neurotransmitter Systems
Hirvonen, J., & Hietala, J. A. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00223.x · Cited by 35
Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats—A possible model for schizophrenia
Baier, P. C., Blume, A., Koch, J. M., Marx, A., Fritzer, G., Aldenhoff, J. B., & Schiffelholz, T. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.018 · Cited by 33
Cellular Reprogramming: Recent Advances in Modeling Neurological Diseases
Ming, G., Brüstle, O., Muotri, A. R., Studer, L., Wernig, M., & Christian, K. M. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4218-11.2011 · Cited by 34
Distinctively higher plasma G72 protein levels in patients with schizophrenia than in healthy individuals
Lin, C.-H., Chang, H., Chen, Y.-J., Lin, C., Huang, C., Tun, R., Tsai, G. E., & Lane, H.-Y. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.80 · Cited by 34
The neural correlates of performance in adolescents at risk for schizophrenia: Inefficiently increased cortico-striatal responses measured with fMRI
Diwadkar, V. A., Pruitt, P. J., Zhang, A., Radwan, J., Keshavan, M. S., Murphy, E. R., Rajan, U., & Zajac‐Benitez, C. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.09.016 · Cited by 35
In vivo 7Tesla imaging of the dentate granule cell layer in schizophrenia
Kirov, I. I., Hardy, C. J., Matsuda, K. M., Walsh‐Messinger, J., Cankurtaran, C. Z., Warren, M., Wiggins, G. C., Perry, N. N., Babb, J. S., Goetz, R. R., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.020 · Cited by 34
Phencyclidine-Induced Decrease of Synaptic Connectivity via Inhibition of BDNF Secretion in Cultured Cortical Neurons
Adachi, N., Numakawa, T., Kumamaru, E., Itami, C., Chiba, S., Iijima, Y., Richards, M., Katoh‐Semba, R., & Kunugi, H. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs074 · Cited by 34
The involvement of N-methyl-d-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia
Ju, P., & Cui, D. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv135 · Cited by 33
B-cells and schizophrenia: A promising link or a finding lost in translation?
van Mierlo, H. C., Broen, J. C. A., Kahn, R. S., & de Witte, L. D. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.06.043 · Cited by 34
Deletion of AMPA receptor GluA1 subunit gene (Gria1) causes circadian rhythm disruption and aberrant responses to environmental cues
Ang, G., Brown, L. A., Tam, S. K. E., Davies, K. E., Foster, F., Harrison, P. J., Sprengel, R., Vyazovskiy, V. V., Oliver, P. L., Bannerman, D. M., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01690-3 · Cited by 36
Self-citation
Review of Major Social Determinants of Health in Schizophrenia-Spectrum Psychotic Disorders: III. Biology
Jeste, D. V., Malaspina, D., Bagot, K. S., Barch, D. M., Cole, S. W., Dickerson, F., Dilmore, A. H., Ford, C. L., Karcher, N. R., Luby, J. L., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbad031 · Cited by 38
Genetic variation in the DAOA gene complex: Impact on susceptibility for schizophrenia and on cognitive performance
Opgen‐Rhein, C., Lencz, T., Burdick, K. E., Neuhaus, A. H., DeRosse, P., Goldberg, T. E., & Malhotra, A. K. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.04.020 · Cited by 34
A preliminary investigation of the impact of catechol-O-methyltransferase genotype on the absorption and metabolism of green tea catechins
Miller, R. J., Jackson, K. G., Dadd, T., Nicol, B., Dick, J. L., Mayes, A. E., Brown, A. L., & Minihane, A. M. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0189-0 · Cited by 34
Altered CSNK1E, FABP4 and NEFH protein levels in the dorsolateral prefrontal cortex in schizophrenia
Pinacho, R., Villalmanzo, N., Meana, J. J., Ferrer, I., Berengueras, A., Haro, J. M., Villén, J., & Ramos, B. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.04.050 · Cited by 33
Altered avalanche dynamics in a developmental NMDAR hypofunction model of cognitive impairment
Seshadri, S., Klaus, A., Winkowski, D. E., Kanold, P. O., & Plenz, D. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0060-z · Cited by 33
Neuroimaging and molecular genetics of schizophrenia: pathophysiological advances and therapeutic potential
Lawrie, S. M., Hall, J., McIntosh, A. M., Owens, D. G. C., & Johnstone, E. C. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707655 · Cited by 34
An organelle proteomic method to study neurotransmission‐related proteins, applied to a neurodevelopmental model of schizophrenia
Vercauteren, F., Flores, G., Ma, W., Chabot, J., Geenen, L., Clerens, S., Fazel, A., Bergeron, J. J. M., Srivastava, L. K., Arckens, L., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200700379 · Cited by 35
Dual Constraints on Synapse Formation and Regression in Schizophrenia: Neuregulin, Neuroligin, Dysbindin, DISC1, MuSK and Agrin
Ao, M. R. B. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670802203467 · Cited by 34
Molecular mechanism of schizophrenia with reference to disrupted-in-schizophrenia 1 (DISC1)
Matsuzaki, S., & Tohyama, M. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.06.018 · Cited by 34
Neonatal infection with neurotropic influenza A virus affects working memory and expression of type III Nrg1 in adult mice
Asp, L., Beraki, S., Kristensson, K., Ögren, S. O., & Karlsson, H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.04.004 · Cited by 33
Neuroimaging and plasticity in schizophrenia
Meyer-Lindenberg, A., & Tost, H. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139014 · Cited by 33
Dysbindin-1 loss compromises NMDAR-dependent synaptic plasticity and contextual fear conditioning
Glen, W. B., Horowitz, B. L., Carlson, G. C., Cannon, T. D., Talbot, K., Jentsch, J. D., & Lavı́n, A. (2013) · Hippocampus · doi:10.1002/hipo.22215 · Cited by 34
Gene-wide association study between the methylenetetrahydrofolate reductase gene (MTHFR) and schizophrenia in the Japanese population, with an updated meta-analysis on currently available data
Yoshimi, A., Aleksić, B., Kawamura, Y., Takahashi, N., Yamada, S., Usui, H., Saito, S., Ito, Y., Iwata, N., Inada, T., et al. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.07.011 · Cited by 33
Clozapine induction of ERK1/2 cell signalling via the EGF receptor in mouse prefrontal cortex and striatum is distinct from other antipsychotic drugs
Pereira, A. M., Sugiharto-Winarno, A., Zhang, B., Malcolm, P., Fink, G., & Sundram, S. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001404 · Cited by 33
Expression of Kruppel-like factor 5 gene in human brain and association of the gene with the susceptibility to schizophrenia
Yanagi, M., Hashimoto, T., Kitamura, N., Fukutake, M., Komure, O., Nishiguchi, N., Kawamata, T., Maeda, K., & Shirakawa, O. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2007.11.042 · Cited by 34
Catechol-O-Methyltransferase Val158Met Polymorphism and Antisaccade Eye Movements in Schizophrenia
Haraldsson, H. M., Ettinger, U., Magnúsdóttir, B. B., Sigmundsson, T., Sigurðsson, E., Ingason, A., & Pétursson, H. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn064 · Cited by 39
Indicated Prevention of Schizophrenia
Klosterkötter, J. (2008) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2008.0532 · Cited by 33
Challenges and opportunities for the development of new antipsychotic drugs
Forray, C., & Buller, R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.05.009 · Cited by 34
Imaging Phenotypes and Genotypes in Schizophrenia
Turner, J. A., Smyth, P., Macciardi, F. M., Fallon, J. H., Kennedy, J. L., & Potkin, S. G. (2006) · Neuroinformatics · doi:10.1385/ni:4:1:21 · Cited by 36
Altered asymmetry of the anterior cingulate cortex in subjects at genetic high risk for psychosis
Park, H. Y., Hwang, J. Y., Jung, W. H., Shin, N. Y., Shim, G., Jang, J. H., & Kwon, J. S. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.08.027 · Cited by 34
Associations of SNAP-25 polymorphisms with cognitive dysfunctions in Caucasian patients with schizophrenia during a brief trail of treatment with atypical antipsychotics
Spellmann, I., Müller, N., Musil, R., Zill, P., Douhet, A., Dehning, S., Cerovecki, A., Bondy, B., Möller, H., & Riedel, M. J. (2008) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0800-9 · Cited by 34
Association Between the G1001C Polymorphism in the GRIN1 Gene Promoter and Schizophrenia in the Iranian Population
Galehdari, H. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9148-5 · Cited by 33
Microvessel length density, total length, and length per neuron in five subcortical regions in schizophrenia
Kreczmański, P., Heinsen, H., Mantua, V., Woltersdorf, F., Masson, T., Ulfig, N., Schmidt‐Kastner, R., Korr, H., Steinbusch, H. W. M., Hof, P. R., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0482-7 · Cited by 33
Reduced auditory M100 asymmetry in schizophrenia and dyslexia: Applying a developmental instability approach to assess atypical brain asymmetry
Edgar, J. C., Yeo, R., Gangestad, S. W., Blake, M. B., Davis, J. T., Lewine, J. D., & Cañive, J. M. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2005.04.016 · Cited by 33
Integrative mixture of experts to combine clinical factors and gene markers
Cao, K. L., Meugnier, E., & McLachlan, G. J. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq107 · Cited by 33
Genetic Association, Mutation Screening, and Functional Analysis of a Kozak Sequence Variant in the Metabotropic Glutamate Receptor 3 Gene in Bipolar Disorder
Kandaswamy, R., McQuillin, A., Sharp, S. I., Fiorentino, A., Anjorin, A., Blizard, R., Curtis, D., & Gurling, H. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.38 · Cited by 32
Schizophrenia: an integrative approach to modelling a complex disorder
Robertson, G. S., Hori, S. E., & Powell, K. J. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0619 · Cited by 34
How has DISC1 enabled drug discovery?
Wang, Q., Jaaro-Peled, H., Sawa, A., & Brandon, N. (2008) · Molecular and cellular neurosciences · doi:10.1016/j.mcn.2007.10.006 · Cited by 36
Six degrees of separation: on the prior probability that schizophrenia susceptibility genes converge on synapses, glutamate and NMDA receptors
Harrison, P. J., & West, V. A. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001886 · Cited by 35
Self-citation
Neuregulin Directly Decreases Voltage-Gated Sodium Current in Hippocampal ErbB4-Expressing Interneurons
Janssen, M. J., Leiva-Salcedo, E., & Buonanno, A. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.1420-12.2012 · Cited by 30
DNA methylation pattern of gene promoters of major neurotransmitter systems in older patients with schizophrenia with severe and mild cognitive impairment
Alelú‐Paz, R., González‐Corpas, A., Ashour, N., Escanilla, A., Monje, A., Márquez, C. G., Weber, M. A., & Ropero, S. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4182 · Cited by 33
Beyond Dopamine: Glutamate as a Target for Future Antipsychotics
Sendt, K.-V., Giaroli, G., & Tracy, D. K. (2012) · ISRN Pharmacology · doi:10.5402/2012/427267 · Cited by 34
Genetic variants in AKT 1 gene were associated with risk and survival of OSCC in Chinese Han Population
Wang, Y., Lin, L., Xu, H. Y., Li, T., Zhou, Y. J., Dan, H., Jiang, L., Liao, G., Zhou, M., Li, L., et al. (2014) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12211 · Cited by 32
Impairment in Functional Capacity as an Endophenotype Candidate in Severe Mental Illness
Harvey, P. D., McClure, M. M., Patterson, T. L., McGrath, J. A., Pulver, A. E., Bowie, C. R., & Siever, L. J. (2011) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr046 · Cited by 32
The p250GAP Gene Is Associated with Risk for Schizophrenia and Schizotypal Personality Traits
Ohi, K., Hashimoto, R., Nakazawa, T., Okada, T., Yasuda, Y., Yamamori, H., Fukumoto, M., Umeda‐Yano, S., Iwase, M., Kazui, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035696 · Cited by 34
Childhood-Onset Schizophrenia: Insights from Induced Pluripotent Stem Cells
Hoffmann, A., Ziller, M. J., & Spengler, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123829 · Cited by 30
Molecular alterations in the medial temporal lobe in schizophrenia
Bobilev, A. M., Perez, J. M., & Tamminga, C. A. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.06.001 · Cited by 34
d -serine and schizophrenia: an update
Nunes, E. A., MacKenzie, E. M., Rossolatos, D., Perez-Parada, J., Baker, G. B., & Dursun, S. M. (2012) · Expert Review of Neurotherapeutics · doi:10.1586/ern.12.65 · Cited by 32
Cell autonomous regulation of hippocampal circuitry via Aph1b-γ-secretase/neuregulin 1 signalling
Fazzari, P., Snellinx, A., Sabanov, V., Ahmed, T., Serneels, L., Gärtner, A., Shariati, S. A., Balschun, D., & Strooper, B. D. (2014) · eLife · doi:10.7554/elife.02196 · Cited by 33
Effects of cognitive remediation on neurocognitive functions and psychiatric symptoms in schizophrenia inpatients
Gharaeipour, M., & Scott, B. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.09.018 · Cited by 32
Positive association of schizophrenia to JARID2 gene
Pedrosa, E., Ye, K. Q., Nolan, K. A., Morrell, L., Okun, J. M., Persky, A. D., Saito, T., & Lachman, H. M. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30386 · Cited by 32

Authors: Harrison, P. J., & Weinberger, D. R.
Affiliations: Warneford Hospital (GB)
National Institutes of Health (US)
ORCID: Harrison, P J
Weinberger, D R
Venue: Molecular Psychiatry
Publisher: Springer Science and Business Media LLC
Published: 2004-07-20
Volume: 10
Issue: 1
Pages: 40-68
ISSN: 1359-4184 (ISSN-L)
1476-5578
DOI: 10.1038/sj.mp.4001558
OpenAlex: W2071090720
Cited by: 2,020
References: 399
Citations by year: 2026: 10 · 2025: 20 · 2024: 22 · 2023: 38 · 2022: 38 · 2021: 34 · 2020: 34 · 2019: 42 · 2018: 52 · 2017: 58 · 2016: 66 · 2015: 88 · 2014: 102 · 2013: 92 · 2012: 129
FWCI: 22.22
Type: journal article
Language: en
Update notices: erratum (2005-03-29)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Molecular Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: schizophrenia, schizophrenia genetics, susceptibility genes, gene expression, synaptic plasticity, cortical microcircuitry, NMDA receptor, glutamatergic neurotransmission, dopamine signalling, GABA signalling, neuregulin, dysbindin, catechol-O-methyltransferase, DISC1, RGS4, GRM3, G72, hippocampus, dorsolateral prefrontal cortex, dorsal thalamus, brain connectivity
MeSH terms: Dysbindin, Brain, Carrier Proteins, Catechol O-Methyltransferase, Gene Expression Regulation, Humans, Schizophrenia, Genetic Predisposition to Disease, Neuregulin-1, Dystrophin-Associated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks